Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • cancer immunotherapies
13 Jan

Israel’s Biond Biologics to get $125 million from Sanofi to develop cancer drug

By admin 0 Comments

Under the terms of license agreement, Biond could get $1 billion as milestones met; Sanofi will be in charge of commercialization and clinical development

Vote up!
Vote down!

Points: 4

Hot

  • Mamdani Gains Surprising Hearing from Satmar Leader in NYC Mayoral Race
  • Shmuel Ellenbogen Wins Republican Primary, Poised to Be Ocean County’s First Frum Commissioner
  • “Greater Danger Than Iran”: Rav Dov Landau, Rav Moshe Hillel Hirsch Demand IDF Draft Resolution, Threaten to Dissolve Knesset on Wednesday

User login

  • Create new account
  • Request new password

Recent comments

No comments available.